Feels like interest dropped once more selective secretagogues came in less cortisol prolactin baggage

GHRPs still work but side effect profile pushed people toward cleaner GH pathways

Hunger spikes from GHRP-6 alone turned many off long-term use

Not decline in efficacy just competition from better-tolerated compounds

Early hype faded once people understood receptor desensitization dynamics

Cortisol response variability made outcomes inconsistent between users

Still useful in specific stacks just not a standalone favorite anymore

Appetite stimulation is a feature for some a dealbreaker for others

Frequency of dosing also made compliance harder vs newer options

Early adopters matured shifted from more GH to better control

Community didn’t lose interest just became more selective

GHRP-2 still has a place if you understand timing and synergy

Not obsolete just no longer the default recommendation.

Knowledge evolution replaced blind stacking with targeted use

Side-effect to benefit ratio doesn’t appeal to newer users

Less marketing hype compared to newer peptides plays a role too